Published in Aliment Pharmacol Ther on June 24, 2015
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome | NCT01339117
Retracted The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J (2016) 1.44
Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol (2016) 1.04
Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr (2016) 0.94
Metabolomics enables precision medicine: "A White Paper, Community Perspective". Metabolomics (2016) 0.93
The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil (2015) 0.91
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87
Letter: avoid FODMAPs or follow simple tips? Aliment Pharmacol Ther (2015) 0.87
Editorial: predicting response to a low FODMAP diet in children. Aliment Pharmacol Ther (2015) 0.87
The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients (2017) 0.78
Logical hypothesis: Low FODMAP diet to prevent diverticulitis. World J Gastrointest Pharmacol Ther (2016) 0.77
Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med (2016) 0.76
Diet and the Gut. Middle East J Dig Dis (2016) 0.76
Microbial signatures in post-infectious irritable bowel syndrome - toward patient stratification for improved diagnostics and treatment. Gut Microbes (2015) 0.76
Lactulose Breath Test Gas Production in Childhood IBS is Associated with Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr (2016) 0.75
Methanosarcina Play an Important Role in Anaerobic Co-Digestion of the Seaweed Ulva lactuca: Taxonomy and Predicted Metabolism of Functional Microbial Communities. PLoS One (2015) 0.75
Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder. Cell Mol Gastroenterol Hepatol (2016) 0.75
Functional Nausea in Children: A Review of the Literature and Need for Diagnostic Criteria. Children (Basel) (2016) 0.75
Dietary Carbohydrates and Childhood Functional Abdominal Pain. Ann Nutr Metab (2016) 0.75
Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) (2017) 0.75
Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunology (2017) 0.75
Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int (2016) 0.75
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Letter: avoid FODMAPs or follow simple tips - authors' reply. Aliment Pharmacol Ther (2015) 0.75
Editorial: predicting response to a low FODMAP diet in children--authors' reply. Aliment Pharmacol Ther (2015) 0.75
Low FODMAP Dietary Food Lists are Often Discordant. Am J Gastroenterol (2017) 0.75
Self-Perceived Food Intolerances Are Common and Associated with Clinical Severity in Childhood Irritable Bowel Syndrome. J Acad Nutr Diet (2016) 0.75
Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients (2017) 0.75
Disruption in the cecal microbiota of chickens challenged with Clostridium perfringens and other factors was alleviated by Bacillus licheniformis supplementation. PLoS One (2017) 0.75
QIIME allows analysis of high-throughput community sequencing data. Nat Methods (2010) 85.34
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol (2006) 57.72
Search and clustering orders of magnitude faster than BLAST. Bioinformatics (2010) 51.97
Structure, function and diversity of the healthy human microbiome. Nature (2012) 30.40
KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res (2011) 30.20
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res (2011) 17.21
Metagenomic biomarker discovery and explanation. Genome Biol (2011) 11.29
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol (2013) 11.05
Diet rapidly and reproducibly alters the human gut microbiome. Nature (2013) 11.04
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med (2008) 2.65
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
Microbial degradation of complex carbohydrates in the gut. Gut Microbes (2012) 2.51
Recurrent abdominal pain of childhood due to lactose intolerance. N Engl J Med (1979) 2.33
Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium. Int J Syst Evol Microbiol (2002) 2.18
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther (2013) 1.84
Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol (2013) 1.79
Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther (2015) 1.78
Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc (2006) 1.77
Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol (2012) 1.72
Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J (2014) 1.63
Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut (2014) 1.54
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51
Conducting a microbiome study. Cell (2014) 1.46
High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun (2014) 1.40
Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology (2007) 1.38
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract (2013) 1.37
Characteristics of pain and stooling in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr (2007) 1.30
The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci (2011) 1.25
Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol (2013) 1.24
Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol (2013) 1.23
Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol (2002) 1.22
Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes (2014) 1.19
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther (2014) 1.14
The diversity of the fecal bacterial community and its relationship with the concentration of volatile fatty acids in the feces during subacute rumen acidosis in dairy cows. BMC Vet Res (2012) 1.14
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13
Creation and initial evaluation of a Stool Form Scale for children. J Pediatr (2010) 1.09
Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev (2009) 1.02
Subtypes of irritable bowel syndrome in children and adolescents. Clin Gastroenterol Hepatol (2014) 0.98
Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther (2014) 0.96
Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther (2013) 0.94
Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. Aliment Pharmacol Ther (2014) 0.93
Comparative genomics and evolution of regulons of the LacI-family transcription factors. Front Microbiol (2014) 0.92
Placebo responses and placebo effects in functional bowel disorders. Eur J Gastroenterol Hepatol (2012) 0.90
Child and parent perceived food-induced gastrointestinal symptoms and quality of life in children with functional gastrointestinal disorders. J Acad Nutr Diet (2013) 0.89
Transcription of two adjacent carbohydrate utilization gene clusters in Bifidobacterium breve UCC2003 is controlled by LacI- and repressor open reading frame kinase (ROK)-type regulators. Appl Environ Microbiol (2014) 0.89
Arabinoxylans and arabinogalactans: a comprehensive treatise. Crit Rev Food Sci Nutr (2011) 0.87
Novel study designs to investigate the placebo response. BMC Med Res Methodol (2011) 0.87
Perception of lactose intolerance in irritable bowel syndrome patients. Eur J Gastroenterol Hepatol (2014) 0.85
Editorial: predicting response to a low FODMAP diet in children--authors' reply. Aliment Pharmacol Ther (2015) 0.75
Fructans Exacerbate Symptoms in a Subset of Children with Irritable Bowel Syndrome. Clin Gastroenterol Hepatol (2017) 0.75